| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
4e-05 |